These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 8059335

  • 1. Imaging endogenous dopamine competition with [11C]raclopride in the human brain.
    Volkow ND, Wang GJ, Fowler JS, Logan J, Schlyer D, Hitzemann R, Lieberman J, Angrist B, Pappas N, MacGregor R.
    Synapse; 1994 Apr; 16(4):255-62. PubMed ID: 8059335
    [Abstract] [Full Text] [Related]

  • 2. Reproducibility of repeated measures of endogenous dopamine competition with [11C]raclopride in the human brain in response to methylphenidate.
    Wang GJ, Volkow ND, Fowler JS, Logan J, Pappas NR, Wong CT, Hitzemann RJ, Netusil N.
    J Nucl Med; 1999 Aug; 40(8):1285-91. PubMed ID: 10450679
    [Abstract] [Full Text] [Related]

  • 3. Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brain.
    Ginovart N, Farde L, Halldin C, Swahn CG.
    Synapse; 1997 Apr; 25(4):321-5. PubMed ID: 9097390
    [Abstract] [Full Text] [Related]

  • 4. Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors.
    Volkow ND, Wang GJ, Fowler JS, Logan J, Angrist B, Hitzemann R, Lieberman J, Pappas N.
    Am J Psychiatry; 1997 Jan; 154(1):50-5. PubMed ID: 8988958
    [Abstract] [Full Text] [Related]

  • 5. Demonstration of competition between endogenous dopamine and [11C]raclopride binding in in vitro brain slices using a dynamic autoradiography technique.
    Sasaki T, Ishiwata K, Murata T, Senda M.
    Synapse; 2002 Apr; 44(1):42-50. PubMed ID: 11842445
    [Abstract] [Full Text] [Related]

  • 6. A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients.
    Farde L, Suhara T, Nyberg S, Karlsson P, Nakashima Y, Hietala J, Halldin C.
    Psychopharmacology (Berl); 1997 Oct; 133(4):396-404. PubMed ID: 9372541
    [Abstract] [Full Text] [Related]

  • 7. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications.
    Volkow ND, Wang GJ, Fowler JS, Logan J, Franceschi D, Maynard L, Ding YS, Gatley SJ, Gifford A, Zhu W, Swanson JM.
    Synapse; 2002 Mar 01; 43(3):181-7. PubMed ID: 11793423
    [Abstract] [Full Text] [Related]

  • 8. 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.
    Vollenweider FX, Vontobel P, Hell D, Leenders KL.
    Neuropsychopharmacology; 1999 May 01; 20(5):424-33. PubMed ID: 10192823
    [Abstract] [Full Text] [Related]

  • 9. Comparable changes in synaptic dopamine induced by methylphenidate and by cocaine in the baboon brain.
    Volkow ND, Fowler JS, Gatley SJ, Dewey SL, Wang GJ, Logan J, Ding YS, Franceschi D, Gifford A, Morgan A, Pappas N, King P.
    Synapse; 1999 Jan 01; 31(1):59-66. PubMed ID: 10025684
    [Abstract] [Full Text] [Related]

  • 10. Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction.
    Volkow ND, Wang GJ, Fowler JS, Hitzemann R, Angrist B, Gatley SJ, Logan J, Ding YS, Pappas N.
    Am J Psychiatry; 1999 Jan 01; 156(1):19-26. PubMed ID: 9892293
    [Abstract] [Full Text] [Related]

  • 11. Dose dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059-01: a study using positron emission tomography and 11C-raclopride.
    Bench CJ, Lammertsma AA, Dolan RJ, Grasby PM, Warrington SJ, Gunn K, Cuddigan M, Turton DJ, Osman S, Frackowiak RS.
    Psychopharmacology (Berl); 1993 Jan 01; 112(2-3):308-14. PubMed ID: 7871035
    [Abstract] [Full Text] [Related]

  • 12. Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: positron emission tomographic studies.
    Koochesfahani KM, de la Fuente-Fernández R, Sossi V, Schulzer M, Yatham LN, Ruth TJ, Blinder S, Stoessl AJ.
    Mov Disord; 2006 Jul 01; 21(7):970-5. PubMed ID: 16570297
    [Abstract] [Full Text] [Related]

  • 13. Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects.
    Dewey SL, Smith GS, Logan J, Brodie JD, Simkowitz P, MacGregor RR, Fowler JS, Volkow ND, Wolf AP.
    Proc Natl Acad Sci U S A; 1993 Dec 15; 90(24):11816-20. PubMed ID: 8265632
    [Abstract] [Full Text] [Related]

  • 14. Effect of endogenous dopamine on extrastriatal [¹¹C]FLB 457 binding measured by PET.
    Okauchi T, Suhara T, Maeda J, Kawabe K, Obayashi S, Suzuki K.
    Synapse; 2001 Aug 15; 41(2):87-95. PubMed ID: 11400175
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma.
    Volkow ND, Wang GJ, Fowler JS, Molina PE, Logan J, Gatley SJ, Gifford A, Ding YS, Wong C, Pappas NR, Zhu W, Swanson JM.
    Psychopharmacology (Berl); 2003 Mar 15; 166(3):264-70. PubMed ID: 12589522
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.
    Volkow ND, Wang G, Fowler JS, Logan J, Gerasimov M, Maynard L, Ding Y, Gatley SJ, Gifford A, Franceschi D.
    J Neurosci; 2001 Jan 15; 21(2):RC121. PubMed ID: 11160455
    [Abstract] [Full Text] [Related]

  • 17. Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats.
    Ginovart N, Wilson AA, Houle S, Kapur S.
    Biol Psychiatry; 2004 Jun 15; 55(12):1188-94. PubMed ID: 15184038
    [Abstract] [Full Text] [Related]

  • 18. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
    Narendran R, Hwang DR, Slifstein M, Talbot PS, Erritzoe D, Huang Y, Cooper TB, Martinez D, Kegeles LS, Abi-Dargham A, Laruelle M.
    Synapse; 2004 Jun 01; 52(3):188-208. PubMed ID: 15065219
    [Abstract] [Full Text] [Related]

  • 19. Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach.
    Breier A, Adler CM, Weisenfeld N, Su TP, Elman I, Picken L, Malhotra AK, Pickar D.
    Synapse; 1998 Jun 01; 29(2):142-7. PubMed ID: 9593104
    [Abstract] [Full Text] [Related]

  • 20. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system.
    Galineau L, Wilson AA, Garcia A, Houle S, Kapur S, Ginovart N.
    Synapse; 2006 Aug 01; 60(2):172-83. PubMed ID: 16715499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.